RefleXion Lands FDA Clearance, Stanford Cancer Institute, And $100 Million

Amongst all the crises and catastrophes created by COVID-19, one company has a cause for celebration. Therapeutic oncology company RefleXion Medical recently announced it closed an equity finance deal worth $100 million. Investors include Canadian-based Public Sector Pension Investment Board, along with J&J Innovation (JJDC), Pfizer Investments, Sofinnova Partners, and others...